Literature DB >> 24011362

Prognostic impact of renal function in precapillary pulmonary hypertension.

R Kaiser1, S Seiler, M Held, R Bals, H Wilkens.   

Abstract

BACKGROUND: Impairment of renal function is associated with adverse outcome in various diseases. Patients with pulmonary hypertension (PH) show diminished cardiac function and organ perfusion. The aim of this study was to investigate the associations between renal function and both haemodynamic parameters and long-term survival in patients with PH.
METHODS: Blood was collected from 64 patients with PH (Dana Point class 1, 3 and 4) during right heart catheterization, and plasma was prepared. Creatinine, blood urea nitrogen (BUN), cystatin C, neutrophil-gelatinase-associated lipocalin (NGAL), fibroblast growth factor 23 (FGF-23) and α-Klotho levels were determined, and glomerular filtration rate (GFR) was estimated (eGFR). Parameters were evaluated using c-statistics and dichotomized for survival analysis based on receiver operating characteristic curves.
RESULTS: The median follow-up time was 9.92 years with all-cause mortality as the primary end-point. Elevated BUN, cystatin C and creatinine levels were associated with decreased survival, with hazard ratios (HRs) of 3.237, 4.514 and 2.006, respectively, and equivalent performance according to c-statistics. Estimating GFR by CKD-EPI, MDRD and Cockcroft-Gault formulas resulted in HRs of 2.942, 2.694 and 3.306, respectively. Amongst these formulas, eGFR (Cockcroft-Gault) had the highest c-statistics of 0.674. There was a correlation between BUN and both cardiac index (τ = -0.39) and pulmonary vascular resistance index (τ = 0.249), whereas eGFR (CKD-EPI) was correlated with cardiac index (τ = 0.225). No correlations between either BUN or eGFR and right atrial pressure (RAP) were observed. NGAL, FGF-23 and α-Klotho had no prognostic impact or association with haemodynamic parameters.
CONCLUSION: Comparison of markers of renal function for prognosis in PH demonstrated superiority of creatinine, cystatin C and BUN over NGAL, FGF-23 and α-Klotho. Minor decreases in eGFR influence long-term prognosis, and measurement of cystatin C levels might be useful to detect renal impairment in patients with a normal serum concentration of creatinine. Renal function in patients with PH is linked to cardiac index rather than RAP.
© 2013 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Keywords:  eGFR; haemodynamics; pulmonary hypertension; renal function; survival

Mesh:

Substances:

Year:  2013        PMID: 24011362     DOI: 10.1111/joim.12131

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  11 in total

1.  Pulmonary Hypertension Subtypes and Mortality in CKD.

Authors:  Daniel L Edmonston; Kishan S Parikh; Sudarshan Rajagopal; Linda K Shaw; Dennis Abraham; Alexander Grabner; Matthew A Sparks; Myles Wolf
Journal:  Am J Kidney Dis       Date:  2019-11-12       Impact factor: 8.860

2.  Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.

Authors:  Rachel Damico; Todd M Kolb; Lidenys Valera; Lan Wang; Traci Housten; Ryan J Tedford; David A Kass; Nicholas Rafaels; Li Gao; Kathleen C Barnes; Raymond L Benza; James L Rand; Rizwan Hamid; James E Loyd; Ivan M Robbins; Anna R Hemnes; Wendy K Chung; Eric D Austin; M Bradley Drummond; Stephen C Mathai; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2015-01-15       Impact factor: 21.405

3.  Pulmonary Arterial Capacitance Predicts Cardiac Events in Pulmonary Hypertension Due to Left Heart Disease.

Authors:  Koichi Sugimoto; Akiomi Yoshihisa; Kazuhiko Nakazato; Yuichiro Jin; Satoshi Suzuki; Tetsuro Yokokawa; Tomofumi Misaka; Takayoshi Yamaki; Hiroyuki Kunii; Hitoshi Suzuki; Shu-Ichi Saitoh; Yasuchika Takeishi
Journal:  PLoS One       Date:  2016-11-22       Impact factor: 3.240

4.  Measurement of Serum Klotho in Systemic Sclerosis.

Authors:  Rossella Talotta; Sara Bongiovanni; Teresa Letizia; Federica Rigamonti; Maria Chiara Ditto; Fabiola Atzeni; Fausto Salaffi; Alberto Batticciotto; Maria Chiara Gerardi; Marco Antivalle; Tarcisio Vago; Maurizio Benucci; Piercarlo Sarzi-Puttini
Journal:  Dis Markers       Date:  2017-08-22       Impact factor: 3.434

5.  Pulmonary hypertension in patients with chronic kidney disease: invasive hemodynamic etiology and outcomes.

Authors:  Jared M O'Leary; Tufik R Assad; Meng Xu; Kelly A Birdwell; Eric Farber-Eger; Quinn S Wells; Anna R Hemnes; Evan L Brittain
Journal:  Pulm Circ       Date:  2017-06-29       Impact factor: 3.017

Review 6.  Kidney dysfunction in patients with pulmonary arterial hypertension.

Authors:  N P Nickel; J M O'Leary; E L Brittain; J P Fessel; R T Zamanian; J D West; E D Austin
Journal:  Pulm Circ       Date:  2017-03-13       Impact factor: 3.017

7.  The level of ROCK1 and ROCK2 in patients with pulmonary hypertension in plateau area.

Authors:  Bing Liu; Rong Chang; Zhili Duan; Xiaofei Zhang; Yusong Shen; Xiangbo Liu; Jinchun Wu; Yajun Tuo; Junming Luo
Journal:  Sci Rep       Date:  2018-06-19       Impact factor: 4.379

8.  Hepatoma-derived Growth Factor Predicts Disease Severity and Survival in Pulmonary Arterial Hypertension.

Authors:  Jun Yang; Melanie K Nies; Zongming Fu; Rachel Damico; Frederick K Korley; Paul M Hassoun; David D Ivy; Eric D Austin; Allen D Everett
Journal:  Am J Respir Crit Care Med       Date:  2016-11-15       Impact factor: 21.405

9.  Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension.

Authors:  Habib Bouzina; Roger Hesselstrand; Göran Rådegran
Journal:  Pulm Circ       Date:  2019-12-27       Impact factor: 3.017

10.  Distinct patterns of soluble leukocyte activation markers are associated with etiology and outcomes in precapillary pulmonary hypertension.

Authors:  Tove Lekva; Lars Gullestad; Kaspar Broch; Pål Aukrust; Arne K Andreassen; Thor Ueland
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.